TUESDAY, Sept. 10, 2024 -- For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure...
Vous n'êtes pas connecté
WEDNESDAY, Aug. 28, 2024 -- Patients treated with high-dose psilocybin have better responses than those treated with placebo in antidepressant trials, according to a study published online Aug. 21 in The BMJ. Tien-Wei Hsu, M.D., from E-DA Dachang...
TUESDAY, Sept. 10, 2024 -- For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure...
WEDNESDAY, Sept. 4, 2024 -- First-generation antihistamines are associated with a higher seizure risk in young children, according to a study...
WEDNESDAY, Sept. 4, 2024 -- Plastic surgery patients who use marijuana also have elevated nicotine levels, according to a study published in the...
WEDNESDAY, Sept. 4, 2024 -- Efforts to rule out bladder tumors and tuberculosis are still essential in the follow-up of patients with suspected...
THURSDAY, Sept. 5, 2024 -- Individuals with acute kidney injury (AKI) have an increased risk for receiving a clinical diagnosis of dementia, according...
FRIDAY, Sept. 6, 2024 -- The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study...
WEDNESDAY, Sept. 4, 2024 -- Among White, but not Black individuals, urinary cadmium (Cd) concentrations are associated with cognitive impairment,...
A new study published in JAMA Network Open reveals that placebos can help relieve chronic back pain, even when patients know they are taking a...
A new study published in JAMA Network Open reveals that placebos can help relieve chronic back pain, even when patients know they are taking a...
TUESDAY, Sept. 3, 2024 -- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a...